Esperion Therapeutics
ESPR
#6169
Rank
ยฃ0.66 B
Marketcap
ยฃ2.80
Share price
-1.58%
Change (1 day)
6.96%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ69.39 Million

According to Esperion Therapeutics's latest financial reports the company has ยฃ69.39 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.11 B78.68%
2023-12-31ยฃ64.55 M-53.19%
2022-12-31ยฃ0.13 B-28.21%
2021-12-31ยฃ0.19 B-14.13%
2020-12-31ยฃ0.22 B46.12%
2019-12-31ยฃ0.15 B42.89%
2018-12-31ยฃ0.10 B-27.66%
2017-12-31ยฃ0.14 B-13.61%
2016-12-31ยฃ0.17 B19.72%
2015-12-31ยฃ0.14 B110.69%
2014-12-31ยฃ67.98 M86.7%
2013-12-31ยฃ36.41 M803.82%
2012-12-31ยฃ4.02 M298.56%
2011-12-31ยฃ1.01 M
2002-12-31ยฃ27.97 M-42.29%
2001-12-31ยฃ48.47 M3.02%
2000-12-31ยฃ47.05 M1187.77%
1999-12-31ยฃ3.65 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ultragenyx Pharmaceutical
RARE
ยฃ0.31 B 359.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.10 B 1,498.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ11.24 B 16,108.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ6.33 B 9,033.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ0.19 B 185.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
ยฃ87.03 M 25.42%๐Ÿ‡บ๐Ÿ‡ธ USA